MDC Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$28,985.61
Insider Selling (Last 12 Months): A$0.00

Medlab Clinical Insider Trading History Chart

This chart shows the insider buying and selling history at Medlab Clinical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medlab Clinical Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for MDC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Medlab Clinical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/8/2022Sean HallInsiderBuy124,821A$0.08A$9,985.68
4/4/2022Sean HallInsiderBuy109,890A$0.09A$9,999.99
3/30/2022Sean HallInsiderBuy95,744A$0.09A$8,999.94
11/4/2021Sean HallInsiderBuy100,000A$0.18A$18,000.00
10/18/2021Cheryl MaleyInsiderIssued1,500,000A$0.16A$240,000.00
11/12/2020Drew TownsendInsiderIssued2,000,000A$0.19A$370,000.00
4/14/2020Michael HallInsiderSell68,707A$0.27A$18,619.60
See Full Table

SEC Filings (Institutional Ownership Changes) for Medlab Clinical (ASX:MDC)

Medlab Clinical logo
Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia.
Read More on Medlab Clinical

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


36,677 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Medlab Clinical?

Medlab Clinical's top insider investors include:
  1. Cheryl Maley (Insider)
  2. Sean Hall (Insider)
Learn More about top insider investors at Medlab Clinical.